German sportswear giant Puma has successfully reached its target of creating nine-tenths of its products using recycled or ...

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that ...

Sports company PUMA is making its 2024 sustainability report accessible for young audiences with the help of video and social ...

Since 2014, Puma’s annual sales have risen to nearly EUR 9 billion from EUR 3 billion as the company has expanded distribution, introduced new products, and stepped up its marketing. At 2.5% ...

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on June 2, 2025, the Compensation ...

Puma and a consortium of other clothing companies have come together to reveal the world's first polyester shirt made ...

Puma said it can’t yet estimate the impact of U.S. tariffs on its outlook, as the German sporting-goods company seeks to get back into shape while it prepares for the arrival of a new chief ...

Nov 6 (Reuters) - German sportswear maker Puma (PUMG.DE), opens new tab is well ... U.S. Freundt said the multinational structure of the company's suppliers allow it to "quite easily" shift ...

HERZOGENAURACH, Germany--(BUSINESS WIRE)--Sports company PUMA has announced its new Vision 2030 sustainability goals, which expand on the strong progress the brand has made. “With Vision 2030 we ...

As such, the Zacks rating upgrade for Puma Biotech is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price. The change in a company's future ...

Sports company PUMA is making its 2024 sustainability report accessible for young audiences with the help of video and social ...